Hepatic arterial infusion chemotherapy with oxaliplatin plus raltitrexed versus oxaliplatin plus fluorouracil in intermediate and advanced hepatocellular carcinoma: A retrospective study.

被引：0
|
作者：
Zang, Mengya
Li, Qi
Hu, Xiaoyun
Yuan, Guosheng
Li, Rong
Guo, Yabing
Chen, Jinzhang
机构：
[1] Southern Med Univ, Hepatol Unit, Nanfang Hosp, Guangzhou, Peoples R China
[2] Southern Med Univ, Dept Infect Dis, Nanfang Hosp, Guangzhou, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16166
引用
收藏
页码：E16166 / E16166
页数：1
相关论文
共 50 条
  • [31] Efficacy and safety of sorafenib plus hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma
    Regmi, Parbatraj
    Hu, Hai-Jie
    Lv, Tian-Run
    Paudyal, Aliza
    Sah, Ram Babu
    Ma, Wen-Jie
    Jin, Yan-Wen
    Li, Fu-Yu
    SURGICAL ONCOLOGY-OXFORD, 2021, 39
  • [32] Lenvatinib plus hepatic arterial infusion chemotherapy with cisplatin for advanced hepatocellular carcinoma.
    Yamamoto, Makoto
    Terashima, Takeshi
    Yamashita, Tatsuya
    Yanagi, Masahiro
    Nakagawa, Hidetoshi
    Seki, Akihiro
    Nio, Kouki
    Arai, Kuniaki
    Toyama, Tadashi
    Yamashita, Taro
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 496 - 496
  • [33] Oxaliplatin plus hydroxycamptothecine versus oxaliplatin plus 5-fluorouracil and leucovorin in treatment of advanced colorectal cancer
    YAO Yang SUN Yuanjue ZHAO Hui GUO Yuewu LIN Feng CAI Xun TANG Xiaochun TANG Lina and ZHANG Wei Department of Oncology Shanghai Sixth Peoples Hospital of Shanghai Jiaotong University Shanghai China Department of Epidemiology Cancer Research Institute of Shanghai Jiaotong University Shanghai China
    ChineseMedicalJournal, 2006, (21) : 1829 - 1833
  • [34] Oxaliplatin plus hydroxycamptothecine versus oxaliplatin plus 5-fluorouracil and leucovorin in treatment of advanced colorectal cancer
    YAO Yang
    中华医学杂志(英文版), 2006, (21) : 1829 - 1833
  • [35] Oxaliplatin plus hydroxycamptothecine versus oxaliplatin plus 5-fluorouracil and leucovorin in treatment of advanced colorectal cancer
    Yao Yang
    Sun Yuan-jue
    Zhao Hui
    Guo Yue-Wu
    Lin Feng
    Cai Xun
    Tang Xiao-chun
    Tang Li-na
    Zhang Wei
    CHINESE MEDICAL JOURNAL, 2006, 119 (21) : 1829 - 1833
  • [36] A randomized phase II study to compare oxaliplatin plus 5-fluorouracil and leucovorin (FOLFOX4) versus oxaliplatin plus raltitrexed (TOMOX) as first-line chemotherapy for advanced colorectal cancer
    Cristina Gravalos
    Antonieta Salut
    Carlos García-Girón
    Rocío García-Carbonero
    Ana Isabel León
    Isabel Sevilla
    Joan Maurel
    Beatriz Esteban
    Eduardo García-Rico
    Adolfo Murias
    Hernán Cortés-Funes
    Clinical and Translational Oncology, 2012, 14 : 606 - 612
  • [37] A randomized phase II study to compare oxaliplatin plus 5-fluorouracil and leucovorin (FOLFOX4) versus oxaliplatin plus raltitrexed (TOMOX) as first-line chemotherapy for advanced colorectal cancer
    Gravalos, Cristina
    Salut, Antonieta
    Garcia-Giron, Carlos
    Garcia-Carbonero, Rocio
    Isabel Leon, Ana
    Sevilla, Isabel
    Maurel, Joan
    Esteban, Beatriz
    Garcia-Rico, Eduardo
    Murias, Adolfo
    Cortes-Funes, Hernan
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2012, 14 (08): : 606 - 612
  • [38] Sorafenib plus hepatic arterial infusion of oxaliplatin and fluorouracil vs sorafenib plus transarterial chemoembolization for advanced hepatocellular carcinoma: A biomolecular exploratory, randomized, phase III trial (SHATA-001).
    Lai, Zhicheng
    Kan, Anna
    He, Minke
    Du, Zefeng
    Shi, Ming
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [39] Phase II Study of Hepatic Arterial Infusion Chemotherapy with Oxaliplatin and 5-Fluorouracil for Advanced Perihilar Cholangiocarcinoma
    Wang, Xiaodong
    Hu, Jungang
    Cao, Guang
    Zhu, Xu
    Cui, Yong
    Ji, Xinqiang
    Li, Xuan
    Yang, Renjie
    Chen, Hui
    Xu, Haifeng
    Liu, Peng
    Li, Jian
    Li, Jie
    Hao, Chunyi
    Xing, Baocai
    Shen, Lin
    RADIOLOGY, 2017, 283 (02) : 580 - 589
  • [40] A phase I study of hepatic arterial infusion of oxaliplatin plus intravenous fluorouracil, leucovorin, and bevacizumab in patients with predominant hepatic metastases
    Fu, S.
    Chintala, L.
    Madoff, D.
    Hong, D. S.
    Naing, A.
    Moulder, S. L.
    Wheler, J. J.
    Ng, C. S.
    Lim, J.
    Patterson, M.
    Kurzrock, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
12345